CDX2, known as a nuclear transcription factor, plays important roles in regulating the epithelial to mesenchymal transition, and acts as a prognostic factor and emerging biomarker in colon cancer (Grainger et al., 2010; Dalerba et al., 2016). The gene discussed is CDX2; the disease is colonic neoplasm.